Spire Wealth Management - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$162,000
+2.5%
148,8000.0%0.01%
+75.0%
Q1 2022$158,000
+39.8%
148,800
+18.3%
0.00%
+33.3%
Q4 2021$113,000
+370.8%
125,800
+598.9%
0.00%
+200.0%
Q3 2021$24,000
-11.1%
18,000
+28.6%
0.00%0.0%
Q2 2021$27,000
+200.0%
14,000
+600.0%
0.00%
Q1 2021$9,0002,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Burrage Capital Management LLC 2,125,585$9,480,0007.68%
DAFNA Capital Management LLC 1,204,825$5,374,0001.28%
Psagot Value Holdings Ltd. 3,095,741$13,807,0000.31%
Ground Swell Capital, LLC 14,684$65,0000.21%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 445,171$1,985,000,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,591$1,350,0000.02%
Phoenix Holdings Ltd. 244,113$1,089,0000.02%
Virtu Financial LLC 27,744$124,0000.01%
D.A. DAVIDSON & CO. 130,700$583,0000.01%
Schonfeld Strategic Advisors LLC 89,278$399,0000.01%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders